-
Action Alerts PLUS
Get free access to Cramer's portfolio picks at Action Alerts PLUS - Try it now Free
-
RealMoney
Jim Cramer's RealMoney team of 70+ Wall Street pros will give you wealth-building strategies - Get started Free
-
RealMoney Silver
Doug Kass + our 5 Premium Services - all in one place - Get a free 14-day trial today
-
Stocks Under $10
David Peltier is ready to help you find affordable Stocks Under $10 which could lead to a big-money payoff - Get access to his portfolio FREE
-
ETF Action
Don Dion's brand new service can help investors at all levels build profitable ETF portfolios - Learn more
CYTK - Cytokinetics Inc
$2.59
-0.05 | -1.89%
-0.05 | -1.89%
Today's Range:
2.52 -
2.66
CYTK Avg. Daily Volume:
599,698
12/21/09 - 4:00 PM ET
TRADE NOW
TheStreet Ratings Grade for CYTK
TheStreet.com Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Click here to find out about our methodology.Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Stong Buy | 6 | 6 | 5 | 5 |
| Moderate Buy | 0 | 0 | 1 | 1 |
| Hold | 2 | 2 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.50 | 1.50 | 1.43 | 1.43 |
Brokerage Partners
Resources
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS: Now any level of investor can trade right alongside a Wall Street pro — and enjoy 24/7 access to his portfolio! Learn More
NEW! Don Dion's ETF Action: A concise two-step strategy for learning and trading in this increasingly lucrative area of investing. For all levels of investors! Learn More
RealMoney: Jim Cramer's team of 70+ investment pros offer a daily wealth of fast-breaking market news... analyses... red-hot opportunities...and wealth-building strategies. Learn More
RealMoney Silver: The genius of Doug Kass + 5 Premium Services = an unrivaled group of expert fundamental analysts, technical analysts, and Wall Street observers. Learn More
Breakout Stocks: Bryan Ashenberg combines sophisticated screening software with eagle-eye analysis to find small and mid-caps ready to break out! Learn More
We respect your privacy.
Podcasts
Connect with TheStreet